Takara Bio Grants Promega Corporation a license for LA-PCR Technology

Sep 10, 2008 --- Takara Bio Inc. (Shiga, Japan) today announced that it has granted Promega Corporation (Wisconsin, U.S) a worldwide non-exclusive license to make, use and sell LA-PCR related products under the patents covering the LA-PCR technology, which Takara Bio owns. Including Promega, the company has twenty two (22) licensees of its LA-PCR technology worldwide. Financial terms of the license were not disclosed.

LA-PCR technology is a breakthrough in PCR (Polymerase Chain Reaction) technology that expands its capability and heightens its application potential considerably. LA-PCR technology overcomes the disadvantages and defects of conventional PCR by enabling high-yield amplification of long and complex DNA fragments from genomic DNA. More importantly for the molecular researcher, DNA molecules produced with LA-PCR technology have significantly fewer mutations than those made using conventional PCR.

LA-PCR is well recognized as an essential technology in the field of genetic engineering around the world. The company continues to promote licensing of this technology as well as sales of its own products worldwide.

[ About Takara Bio Inc. ]

Takara Bio Inc. is an innovative biotechnology company based in Shiga, Japan. As a world leader in biotechnology research and development, Takara Bio was the first company to market PCR technology in Japan and is also the developer of the RetroNectin^® reagent, which is a world-standard in gene therapy protocols. In addition to providing research reagents and equipment to the life science research market, Takara Bio has active research and product development activities in the fields of gene and cell-based therapy, and agricultural biotechnology; and is committed preventing disease and improving the quality of life for all people through the use of biotechnology. Through strategic alliances with other industry leaders, the Company aims to extend its reach around the world. More information is available at http://www.takara-bio.com.

This article is translated from press release in Japanese for your convenience.

Forward-Looking Statements

Statements in this news release, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based on the conclusions of management according to information available at the time of writing, they reflect many assumptions and opinions derived from information that includes major risks and uncertainties. Actual results may vary significantly from these forecasts due to various factors. Factors that could influence actual results include, but are not limited to, economic conditions, especially trends in consumer spending, as well as exchange rate fluctuations, changes in laws and government systems, pressure from competitors' prices and product strategies, decline in selling power of the Company's existing and new products, disruptions to production, violations of our intellectual property rights, rapid advances in technology and unfavorable verdicts in major litigation.